Previous Page  4 / 76 Next Page
Show Menu
Previous Page 4 / 76 Next Page
Page Background


Message from the Chairs

| NCCN Annual Report 2016

It is the NCCN Vision to be the world’s leader in defining and

advancing high-quality, high-value cancer care, and thus we

provide care guidance for patients and providers outside

the United States through translations and adaptations of

the NCCN Guidelines. In 2016 NCCN grew its library of

NCCN Framework for Resource Stratification of NCCN

Guidelines (NCCN Framework


) to include resource-stratified

treatment recommendations for nine NCCN Guidelines. These

frameworks outline rational approaches to cancer care, based

on the highest achievable care and affordable resources in low-

and middle-income countries.

NCCN offers a robust education program that includes live

programs, webcasts, and recorded and online opportunities

to ensure that providers have an understanding of the latest

updates in treatment recommendations within the Guidelines.

The flagship program is the NCCN Annual Conference that

attracts more than 1,600 attendees. In 2017, we look forward

to our 22


Annual Conference in its new location—Orlando,


NCCN set in motion a more robust oncology health care policy

program and presence through an enhanced group of policy

experts at NCCN headquarters, public commentary, live policy

summits, and stakeholder working groups and committees in


The NCCN Oncology Research Program (ORP) achieved an

increase in the number of research grants awarded in 2016.

The ORP funded 10 studies, including three groundbreaking

studies bringing together multiple manufacturers to identify

combination therapies in patients with lung and head and neck

cancers in 2016.

The NCCN Guidelines are the core of the resources and

programs that NCCN is committed to making available to

oncology stakeholders worldwide. Patients are the impetus for

all that we do at NCCN. We could not accomplish our mission

without the support of the NCCN Member Institutions and their

volunteer experts. We want to thank our 27 NCCN Member

Institutions for their tireless dedication to NCCN, and we are

incredibly grateful to the NCCN staff for their dedication to

patient service.

We look forward to further progress in 2017!

With best regards,

Timothy J. Eberlein, MD

Chair, NCCN Board of Directors

Spencer T. And Anne W. Olin Distinguished Professor and

Director of The Alvin J. Siteman Cancer Center

Bixby Professor and Chair of Surgery of the Department of

Surgery at Washington University

Robert W. Carlson, MD

Chief Executive Officer, NCCN